Vasconcelles Michael
- SEC CIK
- 0001734755
In the past year, 1 open-market sale filing worth $31.6K and no purchases.
Current role at each company
- KURA Kura Oncology, Inc.Directoras of Jun 4, 2026
- DAWN Day One Biopharmaceuticals, Inc.Head of Research and Dev.as of Apr 23, 2026
- IMGN ImmunoGen, Inc.EVP R&D & MEDICAL AFFAIRSas of Feb 12, 2024
- DNTH Dianthus Therapeutics, Inc.Directoras of Aug 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $31.6K
- 1 filing
- Net
- −$31.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vasconcelles Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DAWN Day One Biopharmaceuticals, Inc.
Head of Research and Dev.1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Vasconcelles MichaelHead of Research and Dev. | SSale | −2.73K | $11.60 | −$31.6K | −38.3%4.40K after |